维普中文期刊产品整合服务
16篇 您的检索式:作者名="Woitge HW"
    题名 作者 年代 出处 被引量
1Serum bone sialopro- tein as a marker of tumour burden and neoplastic bone involvement and as a prognostic factor in multiple myeloma 显示文摘Woitge HW Pecherstorfer M Horn E 2001Br J Cancer2001,84,3:1
2Serum bone sialoprotein as a marker of tumor burden anti neoplastic bone involvement and as a prognostic factor in multiple mveloma显示文摘Woitge HW Pecherstorfer M Horn E 2001Br J Cancer2001,84,2:1
3Serum bone sialo- protein as a marker of turnout burden and neoplastic bone involve- ment and as a prognostic factor in multiple myeloma显示文摘Woitge HW Pecherstorfer M Horn E 2001Br J Cancer2001,84,3:1
4Serum bone sialoprotein as a marker of tumour burden and neoplastic bone involvement and as a prognostic factor in multiple myeloma显示文摘Woitge HW Pecherstorfer M Horn E 2001Br J Cancer2001,84,3:1
5Novel serum markers of bone resorption clinical assessment and comparison with established urinary indices 显示文摘Woitge HW Peeherstorfer M Li Y 1999J Bone Miner Res1999,14,5:1
6Novel serum markers of bone resorption:clinical assessment and comparison with established urinary indicts显示文摘Woitge HW Pecherstorfer M Li y 1999J Bone Miner Res1999,14,:1
7Serum immunoreactive bone sialoprotein as a new marker of bone turnover in metabolic and malignant bone disease 显示文摘Seibel MJ Woitge HW Pecherstorfer M 1996Clin Endocrinol Metab1996,81,9:1
8Serum bone sialo- protein as a marker of tumour burden and neoplastic bone in- volvement and as a prognostic factor in multiple myeloma 显示文摘Woitge HW Pecherstorfer M Horn E 2001Br J Cancer2001,84,3:1
9Serum bone sialoprotein as a marker of tumour burden and neoplastic bone involvement and as a prognostic factor in multiple my- eloma 显示文摘Woitge HW Pecherstorfer M Horn E 2001Br J Cancer2001,84,3:1
10Serum bone sialoprotein as a marker of tumour burden and neoplastic bone involvement and as a prognostic factor in multiple myeloma显示文摘Woitge HW Pecherstorfer M Horn E 2001Br J Cancer2001,84,3:1
11Transgerdc expression of llbeta-hydroxysteroid dehydrogenase type 2 in osteoblasts reveals an anabolic role for endogenous glueoeorticoids in bone 显示文摘Sher LB Woitge HW Adams D J 2004Endo- crinology2004,145,2:1
12Add-back medrogestone does not prevent bone loss in premenopausal women treated with goserelin显示文摘Sillern M Parviz M Woitge HW 2009Exp Clin Endocrinol Diabetes2009,107,6:1
13Comparison of tolal and bone sepecific alkaline phosphatase in skeletal and non skeletal diseases 显示文摘Woitge HW Seibel M J Ziegler R 1996Clin Chem1996,42,:1
14Novel serum markers of bone resorption:clinical assessment and comparison with established urinary indices显示文摘Woitge HW Pecherstorfer M Li Y 1999J Bone Miner Res1999,14,5:1
15Add-back medrogestone does not prevent bone loss in premenopausal women treated with goserelin显示文摘Sillem M Parviz M Woitge HW 1999Exp Clin Endocrinol Diabetes1999,107,6:1
16Add-back medrogestone doesnot prevent bone loss in premenopausal women treated with goserelin显示文摘Sillern M Parviz M Woitge HW et a1 2009Exp Clin Endocrinol Diabetes2009,107,6:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费